Detalhe da pesquisa
1.
Global treatment rate and barriers to direct-acting antiviral therapy: A systematic review and meta-analysis of 146 studies and 1 760 352 hepatitis C virus patients.
Liver Int
; 43(6): 1195-1203, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825358
2.
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice.
Hepatology
; 74(2): 656-666, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706421